Bridgewater Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,843
Closed -$217K 493
2026
Q1
$217K Sell
2,843
-862
-23% -$82.6K 0.01% 435
2025
Q4
$372K Buy
3,705
+343
+10% +$33.3K 0.02% 323
2025
Q3
$303K Buy
3,362
+496
+17% +$45.6K 0.02% 342
2025
Q2
$265K Buy
2,866
+165
+6% +$14K 0.02% 360
2025
Q1
$228K Buy
+2,701
New +$242K 0.02% 370

Other funds holding MDT

Bridgewater Advisors's MDT Position: Q2 2026 in Review

Bridgewater Advisors sold out of Medtronic (MDT) in Q2 2026, closing a stake of 2,843 shares — an estimated $217K sold.

Bridgewater Advisors first reported a position in MDT in Q1 2025 and held it in 5 quarters. The position peaked at $372K in Q4 2025. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Bridgewater Advisors reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
  • Bridgewater Advisors sold 2,843 Medtronic shares in Q2 2026, an estimated $217K.
  • Bridgewater Advisors first reported a position in Medtronic in Q1 2025 and held it in 5 quarters.
  • Bridgewater Advisors's Medtronic position peaked at $372K in Q4 2025.
  • 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Bridgewater Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.